Show simple item record

dc.contributor.authorStenning Persivale, Karoline Andrea*
dc.contributor.authorSavitzky Franco, Maria Jose*
dc.contributor.authorCordero-Morales, Alejandra*
dc.contributor.authorCruzado-Burga, José*
dc.contributor.authorPoquioma, Ebert*
dc.contributor.authorDíaz Nava, Edgar*
dc.contributor.authorPayet, Edouardo*
dc.date.accessioned2018-02-12T14:57:26Z
dc.date.available2018-02-12T14:57:26Z
dc.date.issued2018-01-18
dc.identifier.citationThe mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Lima 2018, 12 ecancermedicalsciencees
dc.identifier.issn17546605
dc.identifier.doi10.3332/ecancer.2018.799
dc.identifier.urihttp://hdl.handle.net/10757/622636
dc.description.abstractIntroduction: The Mortality–Incidence Ratio complement [1 – MIR] is an indicator validated in various populations to estimate five-year cancer survival, but its validity remains unreported in Peru. This study aims to determine if the MIR correlates directly with five-year survival in patients diagnosed with the ten most common types of cancer in metropolitan Lima. Materials and methods: The Metropolitan Lima Cancer Registry (RCLM in Spanish) for 2004–2005 was used to determine the number of new cases and the number of deaths of the following cancers: breast, stomach, prostate, thyroid, lung, colon, cervical, and liver cancers, as well as non-Hodgkin’s lymphoma and leukaemia. To determine the five-year survival, the five-year vital status of cases recorded was verified in the National Registry of Identification and Civil Status (RENIEC in Spanish). A linear regression model was used to assess the correlation between [1 – MIR] and total observed five-year survival for the selected cancers. Results: Observed and estimated five-year survival determined by [1 – MIR] for each neoplasia were thyroid (66.7%, 86.7%), breast (69.6%; 68%), prostate (64.3%, 63.8%) and cervical (50.1%, 58.5%), respectively. Pearson’s r coefficient for the correlation between [MIR – 1] and observed survival was = 0.9839. Using the coefficient of determination, it was found that [1 – MIR] (X) captures the 96.82% of observed survival (Y). Conclusion: The Mortality–Incidence Ratio complement [1 – MIR] is an appropriate tool for approximating observed five-year survival for the ten types of cancers studied. This study demonstrates the validity of this model for predicting five-year survival in cancer patients in metropolitan Lima.
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherCancer Intelligencees
dc.relation.urlhttp://www.ecancer.org/journal/12/full/799-the-mortality-incidence-ratio-as-an-indicator-of-five-year-cancer-survival-in-metropolitan-lima.phpes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectCanceres
dc.subjectCancer registrieses
dc.subjectIncidencees
dc.subjectMortalityes
dc.subjectMortality/incidence ratioes
dc.subjectPerues
dc.subjectSurvivales
dc.titleThe mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Limaes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.journalecancermedicalsciencees
dc.description.fundingWe would like to thank the Department of Epidemiology and Statistics of the National Cancer Institute (INEN) and the entire departmental staff.es_PE
dc.description.peerreviewRevisión por pareses_PE
refterms.dateFOA2018-06-15T20:30:49Z
html.description.abstractIntroduction: The Mortality–Incidence Ratio complement [1 – MIR] is an indicator validated in various populations to estimate five-year cancer survival, but its validity remains unreported in Peru. This study aims to determine if the MIR correlates directly with five-year survival in patients diagnosed with the ten most common types of cancer in metropolitan Lima. Materials and methods: The Metropolitan Lima Cancer Registry (RCLM in Spanish) for 2004–2005 was used to determine the number of new cases and the number of deaths of the following cancers: breast, stomach, prostate, thyroid, lung, colon, cervical, and liver cancers, as well as non-Hodgkin’s lymphoma and leukaemia. To determine the five-year survival, the five-year vital status of cases recorded was verified in the National Registry of Identification and Civil Status (RENIEC in Spanish). A linear regression model was used to assess the correlation between [1 – MIR] and total observed five-year survival for the selected cancers. Results: Observed and estimated five-year survival determined by [1 – MIR] for each neoplasia were thyroid (66.7%, 86.7%), breast (69.6%; 68%), prostate (64.3%, 63.8%) and cervical (50.1%, 58.5%), respectively. Pearson’s r coefficient for the correlation between [MIR – 1] and observed survival was = 0.9839. Using the coefficient of determination, it was found that [1 – MIR] (X) captures the 96.82% of observed survival (Y). Conclusion: The Mortality–Incidence Ratio complement [1 – MIR] is an appropriate tool for approximating observed five-year survival for the ten types of cancers studied. This study demonstrates the validity of this model for predicting five-year survival in cancer patients in metropolitan Lima.


Files in this item

Thumbnail
Name:
manuscript.pdf
Size:
550.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record